D017427

6 trials

Sponsors

Ogawa Keiko, Yamasaki Kai, Kai Yamasaki, Okamoto Isamu

Conditions

Atypical teratoid rhabdoid tumor Atypical teratoid rhabdoid tumorMedulloblastoma MedulloblastomaTTF-1 negative treatment-naive advanced non-squamous non-small cell lung cancer NSCLC, advanced, driver oncogene negative, TTF-1 negativeTreatment-naive advanced non-squamous non-small cell lung cancer NSCLC, advanced, renal dysfunctionextensive disease small Cell Lung Cancer(ED-SCLC) SCLC, Extensive-Stage, brain metastasistrigeminal neuralgia trigeminal neuralgia, idiopathic trigeminal neuralgia, typical trigeminal neuralgia, carbamazepine refractory

Phase 2

Phase II study of new risk classification and high-dose chemotherapy for medulloblastoma

RecruitingJPRN-jRCTs051200021

Yamasaki KaiMedulloblastoma Medulloblastoma

Start: 2020-06-15Target: 229Updated: 2026-06-29

Phase II study of multimodality treatment for ATRT

RecruitingJPRN-jRCTs051200071

Kai YamasakiAtypical teratoid rhabdoid tumor Atypical teratoid rhabdoid tumor

Start: 2020-10-27Target: 50Updated: 2026-06-29

LOGIK2002(RESTART)

Active, not recruitingJPRN-jRCTs071200102

Okamoto IsamuTreatment-naive advanced non-squamous non-small cell lung cancer NSCLC, advanced, renal dysfunction

Start: 2021-03-18Target: 25Updated: 2026-06-29

LOGIK2001(SPEED)

Active, not recruitingJPRN-jRCTs071210036

Okamoto Isamuextensive disease small Cell Lung Cancer(ED-SCLC) SCLC, Extensive-Stage, brain metastasis

Start: 2021-06-29Target: 41Updated: 2026-06-29

Active, not recruitingJPRN-jRCTs071220008

Okamoto IsamuTTF-1 negative treatment-naive advanced non-squamous non-small cell lung cancer NSCLC, advanced, driver oncogene negative, TTF-1 negative

Start: 2022-07-12Target: 52Updated: 2026-06-29

Placebo-controlled randomized controlled phase II trial of Goreisan in combination with carbamazepine in patients trigeminal neuralgia

Active, not recruitingJPRN-jRCT2061220090

Ogawa Keikotrigeminal neuralgia trigeminal neuralgia, idiopathic trigeminal neuralgia, typical trigeminal neuralgia, carbamazepine refractory

Start: 2023-01-30Target: 24Updated: 2026-06-29

Related Papers

Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial

BMC Cancer2022-09-082 citations